XOMA Royalty Q3 net income $14.1M vs loss $17.2M; revenue $9.4M; cash receipts $43.9M YTD

XOMA Royalty Corp

2025-Q3 EPS reported $1.20 revenue$38,392,000

Net income of $14.1M in Q3 2025, compared to net loss of $17.2M in Q3 2024.
Revenue $9.4M (Q3) and $38.4M (9M), up from $7.2M and $19.8M in prior-year periods.
Cash receipts from partners: $14.3M in Q3; $43.9M in first nine months of 2025.
Recorded $17.9M gain on HilleVax acquisition and $1.8M gain on Turnstone in Q3.
Cash and equivalents $130.6M at Sept 30; repurchased ~108,510 shares for $2.4M YTD.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.